Search This Blog

Monday, September 23, 2019

Aprea Therapeutics sets IPO terms

Aprea Therapeutics (APRE) will offer 5M common shares at $14 – 16 in its IPO.

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.